Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
733 Phase 1 study of ultra-high concentration nitric oxide ablation in relapsed or refractory, unresectable, primary, or metastatic cutaneous and subcutaneous malignancies
Compose a Response to This Article
Other responses
No responses have been published for this article.